Peter Iblher
Hanns Iblher
Brothers receive DGAI’s Thieme Teaching Award
The 5,000 euros award was presented to two brother in recognition of their efforts to organise emergency medical seminars held by students for students.
Germany - Anaesthetists Peter Iblher and Hanns Iblher, who work in the anaesthesiology departments of the Schleswig-Holstein University Hospital, Lubeck, and the Frauenfeld District Hospital respectively, have received the Thieme Teaching Award from the Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin* (DGAI). The 5,000 euros award, sponsored by the scientific publisher Thieme, was presented to the brothers in recognition of their efforts to organise emergency medical seminars held by medical students for medical students.
* The German Society of Anaesthesiology and Intensive Care Medicine
This article was published on 08/30/2006
Search
Service
Company News
Carestream: technical infrastructure for EU funded R-bay project
Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.
Accu-Chek® Combo – put effective diabetes management into action
At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.
Insulin in oral capsules
At the international congress on diabetes in September, Oramed Pharmaceuticals, Inc. introduced its oral insulin capsules that might in the future replace injections patients currently have to face. Last week Oramed announced the agreement with ETI Karle Clinical Pvt. Ltd. to conduct phase 2B clinical trials for its oral insulin capsules.
.jpg&contenttype=jpeg)
